相关实验视频
Updated: Jun 7, 2025

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.6K
心血管临床试验中的贝叶斯分析方法:为什么,何时,如何
Samuel Heuts1, Michal J Kawczynski1, Ahmed Sayed2
1Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands.
The Canadian journal of cardiology
|November 9, 2024
概括
贝叶斯统计方法提供了一种临床直观的方法,通过结合先前的证据来分析心血管试验. 本指南有助于医生理解和执行贝叶斯分析,增强治疗效果估计和不确定性量化.
科学领域:
- 心血管医学 心血管医学
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
背景情况:
- 贝叶斯统计推理在心血管随机试验中越来越多地被使用.
- 了解贝叶斯方法对于执业的心血管医生至关重要,因为它们对指导方针的影响.
- 本综述解决了对心血管研究中贝叶斯分析的清晰指南的需求.
研究的目的:
- 为解释和执行心血管临床试验贝叶斯再分析提供一个逐步指南.
- 为了突出贝叶斯推理对临床读者的优势.
- 通过对现有试验的重新分析来证明贝叶斯方法的清晰性和多功能性.
主要方法:
- 介绍频率主义和贝叶斯统计推理概念.
- 贝叶斯分析的详细步骤:定义研究问题,试验设计,事先诱导,概率识别和后置分布计算.
- 多个prior的透明预规格,以防止后期操纵.
主要成果:
- 贝叶斯分析允许估计治疗效应及其不确定性.
- 后部分布允许计算治疗优势的概率和超过临床重要差异最小值的概率.
- 对三项心血管试验的重新分析表明,贝叶斯推理的实际应用和好处.
结论:
- 贝叶斯统计框架为治疗效应和不确定性提供了临床直观的见解.
- 这种方法提高了心血管临床试验数据的解释.
- 该指南使心血管医生能够自信地将贝叶斯分析应用于他们的实践中.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Kaplan-Meier Approach
100
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
100
Mechanistic Models: Compartment Models in Individual and Population Analysis
29
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
29
Biostatistics: Overview
222
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Discrete variables are...
222
Statistical Methods for Analyzing Epidemiological Data
308
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
308
Actuarial Approach
63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63

